Veritas
Europe
United Kingdom
Spain
Italy
Brazil
Portugal
Colombia
Ecuador
Mexico
Argentina
Latin America
This service is an advanced genetic test that analyses 17 genes known to significantly increase an individual’s risk of developing hereditary breast, gynaecological and colorectal cancer, among others.
£695
Females with breast or ovarian cancer diagnosis, males with breast cancer diagnosis or individuals presenting any cancer type related to Lynch Syndrome.
Family history related to the conditions described above.
The test includes 17 genes related to hereditary breast and ovarian cancer together with Lynch Syndrome, with strong level of evidence as established in NCCNb guidelines, for which specific medical management is defined.
Adding Lynch Syndrome genes to the panel enables the detectionof an additional 10%-15% of the hereditary ovarian cancer cases
uksupport@veritasint.com
